SCHEMBL9248366

SCHEMBL9248366

CS(=O)(=O)OCCN(CCCl)c1ccc(C(N)=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.47
ERBB2 P04626 5/20 0.47
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
CYP3A4 P08684 3/20 0.40
HIF1A Q16665 3/20 0.40
LMNA P02545 3/20 0.40
ALOX15 P16050 2/20 0.40
NFKB1 P19838 2/20 0.40
THPO P40225 2/20 0.40
MAPT P10636 2/20 0.40
PMP22 Q01453 2/20 0.40
ABCB11 O95342 1/20 0.40
CHRM2 P08172 1/20 0.40
ADRA2A P08913 1/20 0.40
CHRM1 P11229 1/20 0.40
ACHE P22303 1/20 0.40
PTGS1 P23219 1/20 0.40
OPRM1 P35372 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1066049 0.88 EGFR (0.49) EGFRERBB2ALDH1A1SMN1; SMN2CYP3A4
SCHEMBL9248362 0.87 EGFR (0.47) EGFRERBB2ALDH1A1SMN1; SMN2CYP3A4
SCHEMBL28280620 0.83 EGFR (0.58) EGFRERBB2ALDH1A1SMN1; SMN2CYP3A4
SCHEMBL13338130 0.80 EGFR (0.48) EGFRERBB2ALDH1A1SMN1; SMN2CYP3A4
SCHEMBL9100336 0.78 CNR2 (0.38) EGFRERBB2ALDH1A1SMN1; SMN2CYP3A4
SCHEMBL6510354 0.78 CA2 (0.53) EGFRERBB2LMNACA12CA1
SCHEMBL9163920 0.77 EGFR (0.53) EGFRERBB2ALDH1A1SMN1; SMN2CYP3A4
SCHEMBL16240875 0.77 ALDH1A1 (0.38) EGFRERBB2ALDH1A1SMN1; SMN2CYP3A4
SCHEMBL1543408 0.76 HPGD (0.50) ALDH1A1SMN1; SMN2CYP3A4LMNAMAPT
SCHEMBL12782495 0.75 CNR2 (0.42) ALDH1A1LMNAALOX15KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0490970-B1 NEW ROUTE OF SYNTHESIS FOR PROTECTED NITROGEN MUSTARD PRODRUGS CANCER RES CAMPAIGN TECH (GB) 1995-03-29 EP disclosed
US-5387707-A Reacting methanesulfonyl chloride with N-(2-chloroethyl)-N-(2-hydroxyethyl) aniline derivatives CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1995-02-07 US disclosed
EP-0490970-A1 NEW ROUTE OF SYNTHESIS FOR PROTECTED NITROGEN MUSTARD PRODRUGS. MANN JOHN (GB) 1992-06-24 EP disclosed
WO-1991003460-A1 NEW ROUTE OF SYNTHESIS FOR TERTIARY ALKYL ESTERS MANN JOHN (GB) 1991-03-21 WO disclosed